Non-infectious aggregates of the prion protein react with several PrP Sc-directed antibodies

Journal of Neurochemistry

Volumn 105, Issue 6, 2008, Pages 2190-2204

  Biasini, Emiliano ^a   Seegulam, M Esa ^a   Patti, Brianna N ^a   Solforosi, Laura ^b   Medrano, Andrea Z ^a   Christensen, Heather M ^a   Senatore, Assunta ^c   Chiesa, Roberto ^c   Williamson, R Anthony ^b   Harris, David A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Monoclonal antibody; Prion; Prion protein; Protein aggregate; PrPSc

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; PRION PROTEIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; BRAIN; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; MICE; MICE, TRANSGENIC; PRIONS; PROTEIN BINDING; PROTEIN ISOFORMS; PRPSC PROTEINS;

EID: 44649192383     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05306.x     Document Type: Article

References (58)

1. Barmada S., Piccardo P., Yamaguchi K., Ghetti B. Harris D. A. (2004) GFP-tagged prion protein is correctly localized and functionally active in the brains of transgenic mice. Neurobiol. Dis. 16, 527 537.
2. Baskakov I. V. Breydo L. (2007) Converting the prion protein: what makes the protein infectious. Biochim. Biophys. Acta 1772, 692 703.
3. Baskakov I. V., Legname G., Baldwin M. A., Prusiner S. B. Cohen F. E. (2002) Pathway complexity of prion protein assembly into amyloid. J. Biol. Chem. 277, 21140 21148.
4. Biasini E., Medrano A. Z., Thellung S., Chiesa R. Harris D. A. (2007) Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertion. J. Neurochem. 104, 1293 1308.
5. Büeler H., Fischer M., Lang Y., Fluethmann H., Lipp H.-P., DeArmond S. J., Prusiner S. B., Aguet M. Weissmann C. (1992) Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577 582.
6. Caughey B. (2001) Interactions between prion protein isoforms: the kiss of death? Trends Biochem. Sci. 26, 235 242.
7. Caughey B. W., Dong A., Bhat K. S., Ernst D., Hayes S. F. Caughey W. S. (1991) Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30, 7672 7680.
8. Chabry J., Priola S. A., Wehrly K., Nishio J., Hope J. Chesebro B. (1999) Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence. J. Virol. 73, 6245 6250.
9. Chiesa R. Harris D. A. (2001) Prion diseases: what is the neurotoxic molecule? Neurobiol. Dis. 8, 743 763.
10. Chiesa R., Piccardo P., Ghetti B. Harris D. A. (1998) Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21, 1339 1351.
11. Chiesa R., Drisaldi B., Quaglio E., Migheli A., Piccardo P., Ghetti B. Harris D. A. (2000) Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc. Natl Acad. Sci. USA 97, 5574 5579.
12. Chiesa R., Piccardo P., Quaglio E., Drisaldi B., Si-Hoe S. L., Takao M., Ghetti B. Harris D. A. (2003) Molecular distinction between pathogenic and infectious properties of the prion protein. J. Virol. 77, 7611 7622.
13. Daude N., Lehmann S. Harris D. A. (1997) Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells. J. Biol. Chem. 272, 11604 11612.
14. Drisaldi B., Stewart R. S., Adles C., Stewart L. R., Quaglio E., Biasini E., Fioriti L., Chiesa R. Harris D. A. (2003) Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J. Biol. Chem. 278, 21732 21743.
15. Fioriti L., Dossena S., Stewart L. R., Stewart R. S., Harris D. A., Forloni G. Chiesa R. (2005) Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J. Biol. Chem. 280, 11320 11328.
16. Gavin B. A., Dolph M. J., Deleault N. R., Geoghegan J. C., Khurana V., Feany M. B., Dolph P. J. Supattapone S. (2006) Accelerated accumulation of misfolded prion protein and spongiform degeneration in a Drosophila model of Gerstmann-Straussler-Scheinker syndrome. J. Neurosci. 26, 12408 12414.
17. Harris D. A. True H. L. (2006) New insights into prion structure and toxicity. Neuron 50, 353 357.
18. Ivanova L., Barmada S., Kummer T. Harris D. A. (2001) Mutant prion proteins are partially retained in the endoplasmic reticulum. J. Biol. Chem. 276, 42409 42421.
19. Jackson G. S., Hosszu L. L., Power A., Hill A. F., Kenney J., Saibil H., Craven C. J., Waltho J. P., Clarke A. R. Collinge J. (1999) Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283, 1935 1937.
20. Kayed R., Head E., Thompson J. L., McIntire T. M., Milton S. C., Cotman C. W. Glabe C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486 489.
21. Sc)-specific epitope defined by a monoclonal antibody. Nature 390, 74 77.
22. C. Proc. Natl Acad. Sci. USA 104, 11551 11556.
23. Legname G., Baskakov I. V., Nguyen H. O., Riesner D., Cohen F. E., DeArmond S. J. Prusiner S. B. (2004) Synthetic mammalian prions. Science 305, 673 676.
24. Lehmann S. Harris D. A. (1996a) Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc. Natl Acad. Sci. USA 93, 5610 5614.
25. Lehmann S. Harris D. A. (1996b) Mutant and infectious prion proteins display common biochemical properties in cultured cells. J. Biol. Chem. 271, 1633 1637.
26. Li A., Christensen H. M., Stewart L. R., Roth K. A., Chiesa R. Harris D. A. (2007) Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO J. 26, 548 558.
27. Lund C., Olsen C. M., Tveit H. Tranulis M. A. (2007) Characterization of the prion protein 3F4 epitope and its use as a molecular tag. J. Neurosci. Methods 165, 183 190.
28. Ma J., Wollmann R. Lindquist S. (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298, 1781 1785.
29. Morel N., Simon S., Frobert Y., Volland H., Mourton-Gilles C., Negro A., Sorgato M. C., Creminon C. Grassi J. (2004) Selective and efficient immunoprecipitation of the disease-associated form of the prion protein can be mediated by nonspecific interactions between monoclonal antibodies and scrapie-associated fibrils. J. Biol. Chem. 279, 30143 30149.
30. Sc. Proc. Natl Acad. Sci. USA 101, 10404 10409.
31. Moroncini G., Mangieri M., Morbin M., Mazzoleni G., Ghetti B., Gabrielli A., Williamson R. A., Giaccone G. Tagliavini F. (2006) Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody. Neurobiol. Dis. 23, 717 724.
32. Nazor K. E., Kuhn F., Seward T. et al. (2005) Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J. 24, 2472 2480.
33. Novitskaya V., Makarava N., Bellon A., Bocharova O. V., Bronstein I. B., Williamson R. A. Baskakov I. V. (2006) Probing the conformation of the prion protein within a single amyloid fibril using a novel immunoconformational assay. J. Biol. Chem. 281, 15536 15545.
34. Pan T., Li R., Kang S. C., Wong B. S., Wisniewski T. Sy M. S. (2004) Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion. J. Neurochem. 90, 1205 1217.
35. Pankiewicz J., Prelli F., Sy M. S., Kascsak R. J., Kascsak R. B., Spinner D. S., Carp R. I., Meeker H. C., Sadowski M. Wisniewski T. (2006) Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. Eur. J. Neurosci. 23, 2635 2647.
36. Paramithiotis E., Pinard M., Lawton T. et al. (2003) A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med. 9, 893 899.
37. Peretz D., Williamson R. A., Matsunaga Y. et al. (1997) A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol. 273, 614 622.
38. Peretz D., Williamson R. A., Kaneko K. et al. (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739 743.
39. Priola S. A. Chesebro B. (1998) Abnormal properties of prion protein with insertional mutations in different cell types. J. Biol. Chem. 273, 11980 11985.
40. Prusiner S. B. (1998) Prions. Proc. Natl Acad. Sci. USA 95, 13363 13383.
41. Prusiner S. B., ed 2004) Prion Biology and Diseases, 2nd Edn, pp. 1050. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
42. Qin K., Yang D.-S., Yang Y., Chishti M. A., Meng L.-J., Kretzschmar H. A., Yip C. M., Fraser P. E. Westaway D. (2000) Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP. Effect of protein age and deamidation. J. Biol. Chem. 275, 19121 19131.
43. Quaglio E., Chiesa R. Harris D. A. (2001) Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform. J. Biol. Chem. 276, 11432 11438.
44. Sc molecules with different conformations. Nat. Med. 4, 1157 1165.
45. Sawaya M. R., Sambashivan S., Nelson R. et al. (2007) Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447, 453 457.
46. Serbec V. C., Bresjanac M., Popovic M., Hartman K. P., Galvani V., Rupreht R., Cernilec M., Vranac T., Hafner I. Jerala R. (2004) Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt-Jacob's disease-affected and normal brain tissue. J. Biol. Chem. 279, 3694 3698.
47. Shaked Y., Engelstein R. Gabizon R. (2002) The binding of prion proteins to serum components is affected by detergent extraction conditions. J. Neurochem. 82, 1 5.
48. Silveira J. R., Raymond G. J., Hughson A. G., Race R. E., Sim V. L., Hayes S. F. Caughey B. (2005) The most infectious prion protein particles. Nature 437, 257 261.
49. Sc interactions. J. Biol. Chem. 282, 7465 7471.
50. Soto C. (2004) Diagnosing prion diseases: needs, challenges and hopes. Nat. Rev. Microbiol. 2, 809 819.
51. Swietnicki W., Morillas M., Chen S. G., Gambetti P. Surewicz W. K. (2000) Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry 39, 424 431.
52. Tessier P. M. Lindquist S. (2007) Prion recognition elements govern nucleation, strain specificity and species barriers. Nature 447, 556 561.
53. Weissmann C. (2004) The state of the prion. Nat. Rev. Microbiol. 2, 861 871.
54. Yin S., Pham N., Yu S. et al. (2007) Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans. Proc. Natl Acad. Sci. USA 104, 7546 7551.
55. Yuan J., Xiao X., McGeehan J., Dong Z., Cali I., Fujioka H., Kong Q., Kneale G., Gambetti P. Zou W. Q. (2006) Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. J. Biol. Chem. 281, 34848 34858.
56. Zahn R., Vonschroetter C. Wüthrich K. (1997) Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding. FEBS Lett. 417, 400 404.
57. Zanusso G., Liu D., Ferrari S. et al. (1998) Prion protein expression in different species: analysis with a panel of new mAbs. Proc. Natl Acad. Sci. USA 95, 8812 8816.
58. Zou W. Q., Zheng J., Gray D. M., Gambetti P. Chen S. G. (2004) Antibody to DNA detects scrapie but not normal prion protein. Proc. Natl Acad. Sci. USA 101, 1380 1385.